PPARs Mediate Lipid Signaling in Inflammation and Cancer.
about
PPARγ as a Novel Therapeutic Target in Lung CancerThe Concise Guide to PHARMACOLOGY 2013/14: nuclear hormone receptors.Anticancer Role of PPARgamma Agonists in Hematological Malignancies Found in the Vasculature, Marrow, and Eyes.Identification of host-immune response protein candidates in the sera of human oral squamous cell carcinoma patients.Anticancer actions of PPARγ ligands: Current state and future perspectives in human lung cancerNovel functions of lipid-binding protein 5 in Caenorhabditis elegans fat metabolism.Changes in plasma PPARs levels in migraine patientsIntegrative and systemic approaches for evaluating PPARβ/δ (PPARD) function.The Mechanism of Interferon Refractoriness During Hepatitis C Virus Infection and Its Reversal with a Peroxisome Proliferator-Activated Receptor α Agonist18β-Glycyrrhetinic acid exerts protective effects against cyclophosphamide-induced hepatotoxicity: potential role of PPARγ and Nrf2 upregulationPPARs in Liver Diseases and Cancer: Epigenetic Regulation by MicroRNAs.PPARβ/δ affects pancreatic β cell mass and insulin secretion in mice.Modeling drug- and chemical-induced hepatotoxicity with systems biology approaches.Microtargeting cancer metabolism: opening new therapeutic windows based on lipid metabolismRecent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME.Cytochrome P450 3A4*22, PPAR-α, and ARNT polymorphisms and clopidogrel responseNuclear receptors in head and neck cancer: current knowledge and perspectives.PPAR Agonists for the Prevention and Treatment of Lung Cancer.PPAR modulation of kinase-linked receptor signaling in physiology and disease.Profiling of promoter occupancy by PPARalpha in human hepatoma cells via ChIP-chip analysis.Metabolic and Inflammatory Adaptation of Reactive Astrocytes: Role of PPARs.The transcriptional PPARβ/δ network in human macrophages defines a unique agonist-induced activation state.Evodiamine might inhibit TGF-beta1-induced epithelial-mesenchymal transition in NRK52E cells via Smad and PPAR-gamma pathway.Telmisartan counteracts TGF-β1 induced epithelial-to-mesenchymal transition via PPAR-γ in human proximal tubule epithelial cells.Proteomic characterization of peroxisome proliferator-activated receptor-γ (PPARγ) overexpressing or silenced colorectal cancer cells unveils a novel protein network associated with an aggressive phenotype.PPARs: Interference with Warburg' Effect and Clinical Anticancer Trials.Activation of PPARγ suppresses proliferation and induces apoptosis of esophageal cancer cells by inhibiting TLR4-dependent MAPK pathway.Cyclooxygenase-independent mechanism of ibuprofen-induced antipyresis: the role of central vasopressin V₁ receptors.Apolipoprotein concentrations are elevated in malignant ovarian cyst fluids suggesting that lipoprotein metabolism is dysregulated in epithelial ovarian cancer.Hesperidin protects against cyclophosphamide-induced hepatotoxicity by upregulation of PPARγ and abrogation of oxidative stress and inflammation.Oxidative Stress in Metabolic Disorders and Drug-Induced Injury: The Potential Role of Nrf2 and PPARs Activators.Brown seaweeds protect against azoxymethane-induced hepatic repercussions through up-regulation of peroxisome proliferator-activated receptor gamma and attenuation of oxidative stress.PPAR-α activation reduced LPS-induced inflammation in alveolar epithelial cells.Hints on ATGL implications in cancer: beyond bioenergetic clues.Detecting Disease Specific Pathway Substructures through an Integrated Systems Biology Approach.Methyl jasmonate enhances the radiation sensitivity of esophageal carcinoma cells by inhibiting the 11-ketoprostaglandin reductase activity ofThe Role of PPARβ/δ in Melanoma Metastasis
P2860
Q28068114-7218CB5F-FA3A-4953-B2AE-134BEF5B28ECQ30486738-F030031E-2DE0-4A03-BF41-95B8FA397914Q33692555-E5058E8E-596E-4A14-A831-26EF6680D287Q34278535-9023ADB2-5B3B-4216-A910-DE23304C9A71Q34878637-CAEAE35D-512B-42D6-891C-C8C17B60575EQ35150105-88C9803F-ECA8-49C6-B425-C582A481FEC8Q35194669-02616498-F931-41B7-845C-F545DBE0CDF2Q35569436-AD29B43C-C6A3-413F-B5D8-68A6A5BE9A51Q35814700-AC6093F4-260F-4CD6-A192-5604F2AFC5D6Q36074465-98C970AC-F2C0-4016-918E-37C6BA98F7B1Q36253614-6B62CF00-1D46-4CD7-A54E-2A84E1321514Q36357760-498B3CB0-94EE-4F91-B49A-26CDF978E436Q36466007-51FECE29-4D0A-49C5-9B05-62AE00BA46A9Q36503853-B477E81F-5CBE-4CA7-9647-2DC6390F8303Q37121662-809CF3EF-244E-4A8D-9658-794E1B648031Q37390889-36240F25-5350-4E2E-8A42-85A6DA5B7D39Q37617222-A1CA0E96-20B6-4083-A8F2-BEDBED10AE15Q37681630-5D97B3D9-1F0D-48BA-9E56-6739BCEC9614Q37765370-72EDD80A-4302-4663-B496-513B9EFB7B92Q38346897-7D04098A-EECA-4632-9181-8A375E218447Q38777732-8D323B12-5257-4BE2-9E73-2662A9428F10Q38879903-5F74CC72-8174-464D-8405-B28617F2002CQ39017725-84A03AD7-A8DD-476A-BA5B-EAFDF10FAE27Q39285206-2ED7C6D1-A570-4049-B5EF-8AF07F5936ADQ39514941-F10EDF4A-C7A3-4B2A-960D-44EB3325E55FQ39609137-AFB4D174-0BC6-4C17-A499-53DDF8871A9CQ39669560-174E5470-1A71-4450-88B4-A0DF0ED897A9Q40343397-36436464-58FD-45EA-B4AD-3A21D033E4C2Q43864805-834BBBCF-0367-47BF-8AE9-EBFC9726AA78Q46390723-0950FE29-801B-480B-B0A7-1EAE00C63AACQ48214408-3208D405-6C06-4C3C-9815-A9AC3CE3DFE7Q48511010-10B72548-AB5B-4718-BB8C-E6C5A0A92721Q51615000-4BA10F80-F066-4F7F-A654-30DB84F47858Q52689159-4F1D046F-481E-4258-9046-7A09B2BD8BA6Q54941802-D627AD34-CA85-4691-9F11-32BAA18032ABQ58781589-D4109EA5-F2A1-49FC-AAB8-9303FFEA82FAQ59138272-C8F92443-130D-4609-9CAA-8E028820D98A
P2860
PPARs Mediate Lipid Signaling in Inflammation and Cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 December 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
PPARs Mediate Lipid Signaling in Inflammation and Cancer.
@en
PPARs Mediate Lipid Signaling in Inflammation and Cancer.
@nl
type
label
PPARs Mediate Lipid Signaling in Inflammation and Cancer.
@en
PPARs Mediate Lipid Signaling in Inflammation and Cancer.
@nl
prefLabel
PPARs Mediate Lipid Signaling in Inflammation and Cancer.
@en
PPARs Mediate Lipid Signaling in Inflammation and Cancer.
@nl
P2860
P356
P1433
P1476
PPARs Mediate Lipid Signaling in Inflammation and Cancer.
@en
P2093
Liliane Michalik
Walter Wahli
P2860
P304
P356
10.1155/2008/134059
P577
2008-12-21T00:00:00Z